A phase I safety and pharmacologic study of a twice weekly dosing regimen of the oral taxane BMS-275183.

Source:http://linkedlifedata.com/resource/pubmed/id/17606724

Clin. Cancer Res. 2007 Jul 1 13 13 3906-12

Download in:

View as

Triples

General Info

PMID
17606724